Topic: Health
A massive study found that medication is the most reliable option for both children and adults with attention deficit hyperactivity disorder (ADHD). Cognitive behavioral therapy also worked well for adults. The research team developed an interactive website to help people make informed decisions about their treatment.
The researchers, from Université Paris Nanterre, Institut Robert-Debré du Cerveau de l'Enfant, and the University of Southampton, examined over 200 meta-analyses to evaluate various treatments for ADHD. They found that medication was the most reliable option for both children and adults, with strong support for five medications used in children and adolescents. For adults, two medications along with cognitive behavioral therapy demonstrated effectiveness with relatively solid evidence.
The study also developed an interactive public website, ebiadhd-database.org, to help people with ADHD and their healthcare providers better understand treatment options. The platform clearly explains how well each intervention is supported by evidence, based directly on the findings of the review.
The researchers emphasized that having accurate information about treatments can empower people with ADHD, leading to better treatment adherence, improved outcomes, and an overall better patient experience.
Why It Matters
This study matters because it provides clear guidance for people with ADHD and their families. It also highlights the importance of shared decision-making between patients and healthcare providers.
Key Facts
- The study found that medication is the most reliable option for both children and adults with ADHD.
- Cognitive behavioral therapy was effective for adults with ADHD, along with two medications.
- The researchers developed an interactive website to help people make informed decisions about their treatment.
- The study evaluated over 200 meta-analyses to evaluate various treatments for ADHD.
- Medication showed strong support for five medications used in children and adolescents.
Key Terms
- ADHD
- Attention deficit hyperactivity disorder, a condition characterized by difficulty paying attention, staying focused, and controlling impulsive behaviors.
Implications
This study matters because it provides clear guidance for people with ADHD and their families. It also highlights the importance of shared decision-making between patients and healthcare providers.
Source: https://www.sciencedaily.com/releases/2026/02/260208233825.htm
Journal Reference:
- Corentin J Gosling, Miguel Garcia-Argibay, Michele De Prisco, Gonzalo Arrondo, Anaël Ayrolles, Stéphanie Antoun, Serge Caparos, Ana Catalán, Pierre Ellul, Maja Dobrosavljevic, Luis C Farhat, Giovanna Fico, Luis Eudave, Annabeth P Groenman, Mikkel Højlund, Lucie Jurek, Mikail Nourredine, Vincenzo Oliva, Valeria Parlatini, Constantina Psyllou, Gonzalo Salazar-de-Pablo, Anneka Tomlinson, Samuel J Westwood, Andrea Cipriani, Christoph U Correll, Dong Keon Yon, Henrik Larsson, Edoardo G Ostinelli, Jae Il Shin, Paolo Fusar-Poli, John P A Ioannidis, Joaquim Radua, Marco Solmi, Richard Delorme, Samuele Cortese. Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making. BMJ, 2025; 391: e085875 DOI: 10.1136/bmj-2025-085875
Leave a Comment